Hormone therapy (HT), involving estrogen alone or combined with progestin, helps alleviate menopausal symptoms. However, its use raises concerns about breast cancer risk, especially with indeterminate calcifications on mammograms. A study by Lochner and Brubaker found no significant difference in malignancy rates between HT users and non-users overall, but estrogen-progestin users had a higher malignancy rate (17.6%) compared to estrogen-only users (5.8%). This suggests the type of HT affects risk. Women should discuss personal risk factors and treatment options with healthcare providers to make informed decisions.

Menopause typically occurs in a woman's late 40s to early 50s and involves the cessation of menstrual cycles and a decrease in hormone levels, leading to various physical and emotional changes. Common symptoms include hot flashes, night sweats, mood swings, and vaginal dryness. Hormone replacement therapy (HRT) helps manage these symptoms by replenishing estrogen and progesterone. While HRT can alleviate severe symptoms and improve quality of life, it carries risks like increased breast cancer and cardiovascular issues. Alternatives include lifestyle changes, nonhormonal medications, and alternative therapies. Discussing with a healthcare provider is essential for a tailored treatment plan.

Hormonal imbalances can cause a range of physical and mental health symptoms in women. Learn how to identify the signs of hormonal imbalances and what steps you can take to manage them.